what happens if you take too much glp 1 GLP-1 receptor agonists GLP-1 Safety Check - National

If so, do you have a suggestion for a medication that would be a good candidate to make the switch

Furthermore, post hoc subgroup analyses of cardiovascular outcome trials have suggested a greater cardiorenal protection in patients treated with a combination versus either monotherapy

[DOI] [PMC free article] [PubMed] [Google Scholar] 922.Day J.W., Ottaway N., Patterson J.T., Gelfanov V., Smiley D., Gidda J

A new Cleveland Clinic analysis of nearly 8,000 patients suggests that discontinuing semaglutide and tirzepatide, on average, does not lead to significant weight regain in clinical practice, as many patients later restart the original medication or try an alternative obesity treatment

But they should not be expected to produce results comparable to prescription weight loss medications

Having that access built into the platform is a nice touch